All Pharmaceuticals articles – Page 8
-
Article
Blockchain: The new frontier for supply chain risk management
A new pilot project currently being explored by the U.S. Food and Drug Administration has enlisted IBM, KPMG, Merck, and Walmart to help determine how to incorporate blockchain into pharmaceutical supply chains.
-
Article
Novartis sets aside $700M in kickback case
Swiss pharmaceutical drug maker Novartis announced it has set aside $700 million for a potential settlement in a long-running lawsuit over allegations that the company paid hundreds of millions of dollars in kickbacks to doctors to induce them into prescribing drugs to patients to boost their sales.
-
Article
Reckitt Benckiser’s record $1.4B opioid settlement a warning for drug companies
Reckitt Benckiser Group will pay $1.4 billion to resolve a long-running federal investigation concerning the sales and marketing of the opioid addiction treatment drug Suboxone.
-
Article
Florida man sentenced for role in collapse of Puerto Rico bank
The CEO of a now-bankrupt pharmaceutical company was sentenced to 30 years in prison for his role in a $100 million plot that triggered Westernbank of Puerto Rico’s collapse.
-
Article
Intra-Cellular Therapies appoints chief compliance officer
Intra-Cellular Therapies, a biopharmaceutical company, has appointed Karen Sheehy as chief compliance officer.
-
Article
Menlo Therapeutics names chief compliance officer
Biopharmaceutical company Menlo Therapeutics has appointed Ronald Krasnow as general counsel and chief compliance officer.
-
Article
Insys files for bankruptcy after $225M settlement
Opioid maker Insys Therapeutics has filed for bankruptcy after agreeing to a $225 million global resolution to settle investigations concerning deceptive marketing and distribution of the drug Subsys.
-
Article
Heritage Pharmaceuticals admits to price fixing, antitrust violations
Heritage Pharmaceuticals, a generic pharmaceutical company headquartered in New Jersey, was charged with conspiring with competitors to fix prices, rig bids, and allocate customers.
-
Article
New rule: Companies must reveal drug costs in TV ads
Under a new rule enacted by the Department of Health and Human Services, pharmaceutical companies will soon be required to disclose in television commercials the price of their prescription drugs that cost more than $35 per month.
-
Article
Jim Massey: The life coach
As a sustainability leader and a fighter for equal access to healthcare, Jim Massey doesn’t just talk the talk; he walks the walk. “It’s about doing the right thing all the time,” he says.
-
Article
Astellas, Amgen to pay $124.75M for False Claims Act violations
Pharmaceutical companies Astellas and Amgen will pay a total of $124.75 million to resolve allegations that they violated the False Claims Act by illegally paying the Medicare co-pays for their own high-priced drugs.
-
Article
Walgreens Boots Alliance names chief accounting officer
Walgreens Boots Alliance, a retail pharmacy company, has named Heather Dixon as its new global controller and chief accounting officer, effective March 18.
-
Article
Indrani Franchini: The champion of culture
For almost 20 years, Indrani Franchini has made a career out of getting to know the industry she is in, creating business relationships that build value and driving cultural change.